Greece Health minister Vassilis Kikilias said on Tuesday that the country will receive in instalments three million doses of the potential COVID-19 vaccine developed by the University of Oxford in collaboration with AstraZeneca if it passes the Phase IV trial, which is expected to be completed in November, as reported Kathimerini.
"At the end of December, January, February, March, May and June, if all goes well, Greece will receive in seven partial deliveries its allocation from the agreed vaccine," Kikilias said.
"We will start with 700,000 doses in December which will be a single or double dose, and around 3 million doses in total," he added.
To read more NewsPoints articles, click here.
About FirstWord Pharma | Upgrade Your FirstWord Pharma | Contact FirstWord Pharma | FirstWord Reports
Advertise with FirstWord Pharma | Industry Partner Showcase
All Contents Copyright © 2021 Doctor's Guide Publishing Limited. All Rights Reserved.
Terms of Use | Privacy Policy